{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:51:47Z","timestamp":1793278307067,"version":"4.5.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of cutaneous T-cell lymphoma (CTCL) increases with age, and blood involvement portends a worse prognosis. To advance our understanding of the development of CTCL and identify potential therapeutic targets, we performed integrative analyses of paired single-cell RNA and T-cell receptor (TCR) sequencing of peripheral blood CD4+ T cells from patients with CTCL to reveal disease-unifying features. The malignant CD4+ T cells of CTCL showed highly diverse transcriptomic profiles across patients, with most displaying a mature Th2 differentiation and T-cell exhaustion phenotype. TCR-CDR3 peptide prediction analysis suggested limited diversity between CTCL samples, consistent with a role for a common antigenic stimulus. Potential of heat diffusion for affinity-based trajectory embedding transition analysis identified putative precancerous circulating populations characterized by an intermediate stage of gene expression and mutation level between the normal CD4+ T cells and malignant CTCL cells. We further revealed the therapeutic potential of targeting CD82 and JAK that endow the malignant CTCL cells with survival and proliferation advantages.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008168","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T11:21:42Z","timestamp":1660130502000},"page":"445-457","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":22,"title":["Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations"],"prefix":"10.1182","volume":"7","author":[{"given":"Jingjing","family":"Ren","sequence":"first","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8258-8287","authenticated-orcid":false,"given":"Rihao","family":"Qu","sequence":"additional","affiliation":[{"name":"2Department of Immunobiology, Yale School of Medicine, New Haven, CT"},{"name":"3Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-7165","authenticated-orcid":false,"given":"Nur-Taz","family":"Rahman","sequence":"additional","affiliation":[{"name":"4Bioinformatics Support Program, Cushing\/Whitney Medical Library, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M.","family":"Lewis","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber Loren Ong","family":"King","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liao","sequence":"additional","affiliation":[{"name":"5Department of Pharmacology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima N.","family":"Mirza","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacie R.","family":"Carlson","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-5195","authenticated-orcid":false,"given":"Yaqing","family":"Huang","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Gigante","sequence":"additional","affiliation":[{"name":"6Computational Biology and Bioinformatics Program, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-4938","authenticated-orcid":false,"given":"Benjamin","family":"Evans","sequence":"additional","affiliation":[{"name":"7Yale Center for Research Computing, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9675-7718","authenticated-orcid":false,"given":"Barani Kumar","family":"Rajendran","sequence":"additional","affiliation":[{"name":"5Department of Pharmacology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-8953","authenticated-orcid":false,"given":"Suzanne","family":"Xu","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Wang","sequence":"additional","affiliation":[{"name":"8Yale Center for Genome Analysis, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-3162","authenticated-orcid":false,"given":"Francine M.","family":"Foss","sequence":"additional","affiliation":[{"name":"9Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"},{"name":"3Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3035-071X","authenticated-orcid":false,"given":"Yuval","family":"Kluger","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Krishnaswamy","sequence":"additional","affiliation":[{"name":"10Department of Genetics, Yale University, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-9343","authenticated-orcid":false,"given":"Michael","family":"Girardi","sequence":"additional","affiliation":[{"name":"1Department of Dermatology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"issue":"19","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Girardi","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/jid.2011.254","article-title":"Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patients","volume":"132","author":"Lin","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.0022-202X.2004.22301.x","article-title":"Genomic aberrations and survival in cutaneous T cell lymphomas","volume":"122","author":"Fischer","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.jid.2018.06.176","article-title":"An integrated data resource for genomic analysis of cutaneous T-cell lymphoma","volume":"138","author":"Chang","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and S\u00e9zary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"issue":"7","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/bloodadvances.2018027482","article-title":"Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing","volume":"3","author":"Iyer","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-18-3309","article-title":"Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression","volume":"25","author":"Borcherding","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"16","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.2020009346","article-title":"Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures","volume":"138","author":"Herrera","year":"2021","journal-title":"Blood"},{"issue":"14","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1158\/1078-0432.CCR-19-0148","article-title":"Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors","volume":"25","author":"Gaydosik","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1159\/000509281","article-title":"Pathogenesis and therapy of primary cutaneous T-cell lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020","volume":"181","author":"Bobrowicz","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3389\/fcell.2020.00851","article-title":"Cellular interactions and inflammation in the pathogenesis of cutaneous T-cell lymphoma","volume":"8","author":"Stolearenco","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/bloodadvances.2020001756","article-title":"JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL","volume":"4","author":"Yumeen","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"e0248298","DOI":"10.1371\/journal.pone.0248298","article-title":"Ruxolitinib with resminostat exert synergistic antitumor effects in cutaneous T-cell lymphoma","volume":"16","author":"Karagianni","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"2023021422370760200_","first-page":"111","article-title":"Insights Into the molecular and cellular underpinnings of cutaneous T cell lymphoma","volume":"93","author":"Yumeen","year":"2020","journal-title":"Yale J Biol Med"},{"key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fonc.2019.00300","article-title":"Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL)","volume":"9","author":"Ghazawi","year":"2019","journal-title":"Front Oncol"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2013-05-500686","article-title":"Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma","volume":"123","author":"Chevret","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1056::AID-CNCR23>3.0.CO;2-#","article-title":"Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma","volume":"86","author":"Wu","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41598-021-83352-4","article-title":"Genomics England Research Consortium. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma","volume":"11","author":"Jones","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/php.12377","article-title":"UV signature mutations","volume":"91","author":"Brash","year":"2015","journal-title":"Photochem Photobiol"},{"issue":"5","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2015.12.018","article-title":"Cutaneous T-cell lymphoma (CTCL): current practices in blood assessment and the utility of T-cell receptor (TCR)-V\u03b2 chain restriction","volume":"74","author":"Gibson","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"19","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","article-title":"Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells","volume":"114","author":"Robins","year":"2009","journal-title":"Blood"},{"issue":"308","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"308ra158","DOI":"10.1126\/scitranslmed.aaa9122","article-title":"TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL","volume":"7","author":"Kirsch","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1582-4934.2007.00170.x","article-title":"Cancer stem cells: the lessons from pre-cancerous stem cells","volume":"12","author":"Gao","year":"2008","journal-title":"J\u00a0Cell Mol Med"},{"issue":"4","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1055-9965.EPI-13-0084","article-title":"Precursors in cancer epidemiology: aligning definition and function","volume":"22","author":"Wacholder","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41587-019-0336-3","article-title":"Visualizing structure and transitions in high-dimensional biological data","volume":"37","author":"Moon","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"5","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/1521-4141(200205)32:5<1328::AID-IMMU1328>3.0.CO;2-6","article-title":"Distinctive signaling pathways through CD82 and beta1 integrins in human T cells","volume":"32","author":"Iwata","year":"2002","journal-title":"Eur J Immunol"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1038\/leu.2015.219","article-title":"The novel function of CD82 and its impact on BCL2L12 via AKT\/STAT5 signal pathway in acute myelogenous leukemia cells","volume":"29","author":"Nishioka","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4049\/jimmunol.155.1.101","article-title":"CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T\u00a0cell activation","volume":"155","author":"Lebel-Binay","year":"1995","journal-title":"J\u00a0Immunol"},{"issue":"23","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"btab358","DOI":"10.1093\/bioinformatics\/btab358","article-title":"Cellsnp-lite: an efficient tool for genotyping single cells","volume":"37","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"2023021422370760200_","unstructured":"Tickle TTI , GeorgescuC, BrownM, HaasB. inferCNV of the Trinity CTAT Project. Accessed 21 October 2021. Available at:https:\/\/githubcom\/broadinstitute\/inferCNV."},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"issue":"21","key":"2023021422370760200_","article-title":"Molecular pathogenesis of cutaneous T cell lymphoma: role of chemokines, cytokines, and dysregulated signaling pathways","volume":"S1044-579X","author":"Patil","year":"2021","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41590-021-00982-6","article-title":"Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving\u00a0functional T cell memory","volume":"22","author":"Tonnerre","year":"2021","journal-title":"Nat Immunol"},{"issue":"8","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","article-title":"Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation","volume":"22","author":"Abdel-Hakeem","year":"2021","journal-title":"Nat Immunol"},{"issue":"7","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/eji.202049043","article-title":"CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver","volume":"51","author":"Nicolay","year":"2021","journal-title":"Eur J Immunol"},{"issue":"9","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1470-2045(18)30449-2","article-title":"CCR4-targeted therapy in cutaneous T-cell lymphoma","volume":"19","author":"Gniadecki","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol"},{"issue":"18","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.28348","article-title":"CD82 regulates STAT5\/IL-10 and supports survival of acute myelogenous leukemia cells","volume":"134","author":"Nishioka","year":"2014","journal-title":"Int J Cancer"},{"issue":"6","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1159\/000455944","article-title":"Risk factors for skin infections in mycosis fungoides","volume":"232","author":"Lebas","year":"2016","journal-title":"Dermatology"},{"issue":"3","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood.V99.3.973","article-title":"Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3","volume":"99","author":"Nielsen","year":"2002","journal-title":"Blood"},{"issue":"18","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2015.02.014","article-title":"Improved pruritus correlates with lower levels of IL-31 in patients with CTCL under different therapeutic modalities","volume":"158","author":"Cedeno-Laurent","year":"2015","journal-title":"Clin Immunol"},{"issue":"8","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1182\/blood.V99.8.2929","article-title":"The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells","volume":"99","author":"Berger","year":"2002","journal-title":"Blood"},{"issue":"12","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4081::AID-IMMU4081>3.0.CO;2-I","article-title":"Overexpression of CD82 on human T cells enhances LFA-1 \/ ICAM-1-mediated cell-cell adhesion: functional association between CD82 and LFA-1 in T cell activation","volume":"29","author":"Shibagaki","year":"1999","journal-title":"Eur J Immunol"},{"issue":"17","key":"2023021422370760200_","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/CIRCULATIONAHA.114.011096","article-title":"CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells","volume":"130","author":"Wei","year":"2014","journal-title":"Circulation"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/3\/445\/2033356\/blooda_adv-2022-008168-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/3\/445\/2033356\/blooda_adv-2022-008168-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T08:36:20Z","timestamp":1700901380000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/3\/445\/486179\/Integrated-transcriptome-and-trajectory-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,2,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008168","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742274159.793594811","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}